"[T]he plaintiffs ... allege that Wells Fargo paid its pharmacy benefit manager high prices for generic drugs that were available at significantly lower prices ... [and] that most of the increased cost was paid by plan assets.... The suit also alleges that Wells Fargo paid too much in administrative fees compared to plans both similar in size to and smaller than the Wells Fargo plan." [Navarro v. Wells Fargo & Co., No. 24-3043 (D. Minn. complaint filed Jul. 30, 2024)]  MORE >>